Project summary:

MAYA addresses the third intervention outlined in the call by developing, testing, and scaling up innovative, holistic approaches and tools for managing late effects of cancer treatment in AYA cancer (of any type) survivors. MAYA aims to empower Adolescents and Young Adults (AYA) cancer survivors to manage their cardiovascular (CV) health through digital tools that address cardiotoxic-related late effects of cancer treatment. The project envisions using the iCARE health hub, which integrates a smart mirror and an AI-powered conversational agent, to deliver personalised care and continuous monitoring. The ultimate goal is to improve cardiovascular outcomes and overall quality of life for AYA survivors by managing modifiable risk factors such as hypertension, diabetes, and obesity, with an expected reduction in the risk of major cardiac events by 30-40%. MAYA will achieve these objectives through advanced AI-driven data analysis, real-time biomarker tracking, and participatory research methods including social innovation, multistakeholder engagement, and Living Labs. The project will test these solutions in real-world settings through clinical studies involving AYA cancer survivors in multiple European countries. By focusing on personalised interventions and continuous health monitoring, MAYA directly aligns with the objectives of the Horizon Europe work programme, particularly the Cancer Mission's goals of improving long-term health outcomes and quality of life for cancer survivors. Additionally, the project contributes to the work programme’s emphasis on innovation in healthcare and equity across diverse healthcare systems. This action is part of the Cancer Mission cluster of projects on “Quality of life (AYA).

PI: María José Santofimia Romero

Link: